Citation: | TANG Dai-rong, XIE Xian-da, LIAO Xiang-ping. Clinical significance of urine hepcidin in lupus nephritis[J]. Journal of Clinical Nephrology, 2017, 17(8): 490-494. DOI: 10.3969/j.issn.1671-2390.2017.08.009 |
[1] |
Brugos B, Zeher M. Biomarkers in lupus nephritis[J]. Orv Hetil, 2010, 151(29):1171-1176.
|
[2] |
Balow JE. Clinical presentation and monitoring of lupus nephritis[J]. Lupus, 2005, 14(1):25-30.
|
[3] |
Ashby DR, Gale DP, Busbridge M, et al. Plasma Hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease[J]. Kidney Int, 2009, 75(9):976-981.
|
[4] |
Bennett M, Bruner HI. Biomarkers and updates on pediatrics lupus nephritis[J]. Rheum Dis Clin North Am, 2013, 39(4):833-853.
|
[5] |
Swinkels DW, Girelli D, Laarakkers C, et al. Advances in quantitative Hepcidin measurements by time-of-flight mass spectrometry[J]. PLoS One, 2008, 3(7):e2706.
|
[6] |
Jelic M, Cvetkovic T, Djordjevic V, et al. Hepcidin and iron metabolism disorders in patients with chronic kidney disease[J]. Vojnosanit Pregl, 2013, 70(4):368-373.
|
[7] |
Fufaa GD, Weil EJ, Nelson RG, et al. Urinary monocyte chemoattractant protein-1 and Hepcidin and early diabetia nephropathy lesion in type 1 diabetes mellitus[J]. Nephrol Dial Transplant, 2015, 30(4):599-606.
|
[8] |
袁红, 曾雪曦. 狼疮性肾炎的研究进展[J]. 国际检验医学杂志, 2016, 37(4):523-526.
|
[9] |
Mohammed MF, Belal D, Bakry S, et al. A study of Hepcidin and monocyte chemoattractant protein-1 in Egyptian females with systemic lupus erythematosus[J]. J Clin Lab Anal, 2014, 28(4):306-309.
|
[10] |
Zhang X, Nagaraja HN, Nadasdy T, et al. A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies[J]. Kidney Int, 2012, 81(4):401-406.
|
[11] |
Bennett M, Brunner HI.Biomarkers and updates on pediatrics lupus nephritis[J]. Rheum Dis Clin N Am, 2013, 39(4):833-853.
|
[12] |
Zhang X, Jin M, Wu H, et al. Biomarkers of lupus nephritis determined by serial urine proteomics[J]. Kidney Int, 2008, 74(6):799-807.
|
[13] |
Troutt JS, Butterfield AM, Konrad RJ. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates[J]. J Clin Lab Anal, 2013, 27(6):504-510.
|
[14] |
Lukaszyk E, Lukaszyk M, Koc-Zorawska E, et al. Iron status and inflammation in early stages of chronic kidney disease[J]. Kidney Blood Press Res, 2015, 40(4):366-373.
|
[15] |
Parodis I, Zickert A, Sundelin B, et al. Evaluation of B lymphocyte stimulator and a proliferation inducing ligand ascandidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy[J]. Lupus Sci Med, 2015, 2(1):e000061.
|
[16] |
常春康, 张曦, 肖超, 等. 铁调素的表达与调节机制研究进展[J]. 中国实验血液学杂志, 2012, 20(4):1030-1033.
|
[17] |
Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing it internalization[J]. Science, 2004, 306(5704):2090-2093.
|
[18] |
Indrakanti DL, Alvarado A, Zhang X, et al. The interleukin-6-Hepcidin-hemoglobin circuit in systemic lupus erythematosus flares[J]. Lupus, 2016:0, 1-4.
|